On this page

ZIMECTERIN® Gold Paste

Ivermectin Praziquantel

Veterinary NADA Approved 119,100 adverse event reports

Overview

Source: Animal Drugs @ FDA
Proprietary name
ZIMECTERIN® Gold Paste
Active ingredient
Ivermectin Praziquantel
Application type
NADA
Sponsor
Boehringer lngelheim Animal Health USA, Inc.
Applications on record
1
First published
July 26, 2021

Adverse event reports

Source: openFDA VeDDRA
119,100
Reports mentioning this ingredient
January 2, 1987 – March 27, 2026
43,067
Classified serious
per reporter assessment
70,863
Lack of expected efficacy
resistance signal
1,189
Human operator exposure
needle-stick or splash
Not a risk measure. Veterinary adverse event reports are influenced by how many animals are treated, reporting practice and product age. Reports do not establish that the product caused the event, and a single report can cover an entire herd or flock. Attribution here is by active ingredient because the source dataset redacts brand names.

Attributed by active ingredient “IVERMECTIN”. Green Book ingredient names and VeDDRA ingredient names do not always agree exactly, so attribution is approximate and labelled as such.

Reported reactions

Source: openFDA VeDDRA

Clinical signs coded in the VICH VeDDRA four-level hierarchy, most frequent first.

Reaction terms reported for this ingredient, by report count.
Reaction (VeDDRA term) Reports Relative frequency
Lack of efficacy (endoparasite) - heartworm 20,312
Lack of efficacy (endoparasite) - hookworm 14,429
Digestive tract disorder NOS 12,826
INEFFECTIVE, HEARTWORM LARVAE 12,510
Vomiting 9,319
INEFFECTIVE, HOOKS 6,797
Cardiac disorder NOS 6,522
Lack of efficacy - NOS 5,397
Tablets, Abnormal 5,160
Lack of efficacy (endoparasite) - roundworm NOS 4,982
Diarrhoea 4,429
INEFFECTIVE, ASCARIDS NOS 4,424
Lethargy (see also Central nervous system depression in 'Neurological') 2,489
Death 2,385
Containers, Damaged 2,185
Ataxia 1,780
Lack of efficacy (protozoa) - Coccidia 1,618
Underdose 1,563
Hard, clumping 1,498
Overdose 1,448

Species affected

Source: openFDA VeDDRA
Dog 103,255 Cattle 1,779 Horse 1,184 Cat 930 Human 498 Sheep 218 Pig 125 Goat 65 Other 39 Rabbit 31 Guinea Pig 24 Donkey 22

Regulatory context

New Animal Drug Application (NADA). A pioneer approval evaluated for target animal safety, therapeutic effectiveness, manufacturing controls and — for food-producing species — human food safety including residue depletion.

Extra-label use in food-producing animals is governed by the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) and 21 CFR Part 530. It requires a valid veterinarian-client-patient relationship and is prohibited outright for certain drug classes. Withdrawal times are determined by FARAD, not by this index.

Sources for this page

Animal Drugs @ FDA FDA CVM Applications, sponsor, status, withdrawal
Animal & Veterinary Events FDA CVM VeDDRA adverse event aggregates by active ingredient